NantHealth (NASDAQ: NH) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it weigh in compared to its competitors? We will compare NantHealth to related businesses based on the strength of its valuation, dividends, earnings, institutional ownership, risk, profitability and analyst recommendations.

Profitability

This table compares NantHealth and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NantHealth -225.76% -46.09% -25.23%
NantHealth Competitors -14.47% -7.27% 0.23%

Analyst Recommendations

This is a summary of current ratings and target prices for NantHealth and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth 0 0 4 0 3.00
NantHealth Competitors 88 439 833 13 2.56

NantHealth currently has a consensus target price of $9.00, indicating a potential upside of 178.64%. As a group, “Medical Software & Technology Services” companies have a potential upside of 17.55%. Given NantHealth’s stronger consensus rating and higher possible upside, analysts plainly believe NantHealth is more favorable than its competitors.

Institutional & Insider Ownership

7.1% of NantHealth shares are owned by institutional investors. Comparatively, 62.8% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 58.0% of NantHealth shares are owned by company insiders. Comparatively, 24.5% of shares of all “Medical Software & Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares NantHealth and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
NantHealth $100.38 million -$184.10 million -2.21
NantHealth Competitors $413.57 million -$24.55 million 404.09

NantHealth’s competitors have higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

NantHealth competitors beat NantHealth on 7 of the 11 factors compared.

NantHealth Company Profile

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.